HC Wainwright & Co. Reiterates Buy on HilleVax, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Matthew Caufield has reiterated a Buy rating on HilleVax (NASDAQ:HLVX) and maintained a $28 price target.

March 21, 2024 | 10:27 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating on HilleVax with a $28 price target.
The reiteration of a Buy rating and a maintained price target of $28 by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could lead to a positive short-term impact on HilleVax's stock price. Analyst ratings, especially from well-regarded firms, often influence investor perception and can lead to price movements.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100